Table 2.
6-Month retention (n = 22,680), aOP [95% CI] | 12-Month retention (n = 15,604), aOR [95% CI] | Viral suppression (n = 7,674), aOR [95% CI] | |
---|---|---|---|
| |||
CASG member | |||
No | Ref. | Ref. | Ref. |
Yes | 4.19 [3.79–4.64] | 4.43 [4.01–4.90] | 1.14 [1.02–128] |
Sex | |||
Female | Ref. | Ref. | Ref. |
Male | 0.90 [0.82–0.99] | 0.80 [0.73–0.88] | 0.72 [0.62–0.82] |
Age at CASG eligibility, yearsa | |||
20 | 0.82 [0.70–0.95] | 0.72 [0.60–0.87] | 0.85 [0.77–0.93] |
35 | Ref. | Ref. | Ref. |
50 | 1.23 [0.95–1.59] | 1.08 [0.82–1.43] | 1.27 [1.10–1.46] |
Highest educational level attained | |||
None | 1.03 [0.92–1.14] | 0.97 [0.88–1.08] | 1.06 [0.91–1.23] |
Primary | Ref. | Ref. | Ref. |
Post-secondary | 1.06 [0.95–1.19] | 1.06 [0.93–1.22] | 1.34 [1.14–1.59] |
Marital status | |||
Cohabitating with partner | Ref. | Ref. | Ref. |
Married | 0.99 [0.88–1.11] | 0.98 [0.87–1.11] | 1.14 [0.94–1.38] |
Separated/divorced/widowed/single | 1.06 [0.96–1.17] | 0.98 [0.89–1.09] | 1.07 [0.94–1.21] |
CD4 cell count (cell/mm3)a | |||
150 | 0.97 [0.66–1.10] | 0.95 [0.82–1.10] | 0.82 [0.75–0.90] |
300 | Ref. | Ref. | Ref. |
500 | 1.02 [0.95–1.09] | 1.00 [0.93–1.09] | 1.18 [1.12–1.24] |
Health facility location—district | |||
Quelimane | Ref. | Ref. | Ref. |
Gilé | 0.54 [0.45–0.65] | 0.50 [0.42–0.61] | 0.43 [0.34–0.54] |
Ile | 0.82 [0.65–1.04] | 0.69 [0.53–0.90] | 0.45 [0.35–0.60] |
Inhassunge | 0.52 [0.44–0.62] | 0.47 [0.39–0.56] | 0.80 [0.62–1.01] |
Maganja da Costa | 0.45 [0.38–0.53] | 0.31 [0.26–0.38] | 0.53 [0.42–0.65] |
Mocubela | 0.50 [0.43–0.59] | 0.33 [0.28–0.39] | 0.87 [0.65–1.16] |
Alto Molócué | 0.64 [0.51–0.80] | 0.61 [0.48–0.79] | 0.64 [0.48–0.87] |
Namacurra | 0.60 [0.52–0.70] | 0.63 [0.54–0.74] | 0.63 [0.52–0.77] |
Pebane | 0.74 [0.64–0.85] | 0.68 [0.59–0.80] | 0.87 [0.70–1.08] |
Age and CD4 cell count values were fitted using restricted cubic splines.
aOR, adjusted odds ratio.